Predicting T-cell quality during manufacturing through an artificial intelligence-based integrative multiomics analytical platform

11Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Large-scale, reproducible manufacturing of therapeutic cells with consistently high quality is vital for translation to clinically effective and widely accessible cell therapies. However, the biological and logistical complexity of manufacturing a living product, including challenges associated with their inherent variability and uncertainties of process parameters, currently make it difficult to achieve predictable cell-product quality. Using a degradable microscaffold-based T-cell process, we developed an artificial intelligence (AI)-driven experimental-computational platform to identify a set of critical process parameters and critical quality attributes from heterogeneous, high-dimensional, time-dependent multiomics data, measurable during early stages of manufacturing and predictive of end-of-manufacturing product quality. Sequential, design-of-experiment-based studies, coupled with an agnostic machine-learning framework, were used to extract feature combinations from early in-culture media assessment that were highly predictive of the end-product CD4/CD8 ratio and total live CD4+ and CD8+ naïve and central memory T cells (CD63L+CCR7+). Our results demonstrate a broadly applicable platform tool to predict end-product quality and composition from early time point in-process measurements during therapeutic cell manufacturing.

References Powered by Scopus

NMRPipe: A multidimensional spectral processing system based on UNIX pipes

12327Citations
N/AReaders
Get full text

Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation

2368Citations
N/AReaders
Get full text

Adoptive cell transfer as personalized immunotherapy for human cancer

1970Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Development of a Robust Consensus Modeling Approach for Identifying Cellular and Media Metabolites Predictive of Mesenchymal Stromal Cell Potency

7Citations
N/AReaders
Get full text

A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells

6Citations
N/AReaders
Get full text

Virtual differential phase-contrast and dark-field imaging of x-ray absorption images via deep learning

5Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Odeh-Couvertier, V. Y., Dwarshuis, N. J., Colonna, M. B., Levine, B. L., Edison, A. S., Kotanchek, T., … Torres-Garcia, W. (2022). Predicting T-cell quality during manufacturing through an artificial intelligence-based integrative multiomics analytical platform. Bioengineering and Translational Medicine, 7(2). https://doi.org/10.1002/btm2.10282

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

56%

Researcher 5

28%

Professor / Associate Prof. 2

11%

Lecturer / Post doc 1

6%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 5

42%

Engineering 3

25%

Chemical Engineering 2

17%

Chemistry 2

17%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 39

Save time finding and organizing research with Mendeley

Sign up for free